Local doctors share tips for allergy relief and long-term treatment options.

Robust real-world data on the effectiveness of biologic therapies in children with severe asthma remain limited, particularly ...

Move comes 2 years after controversial exit of brand-name product ...

A new study led by investigators at National Jewish Health and published in Annals of Allergy, Asthma & Immunology shows that ...

Nonclinical factors are more likely to drive discontinuation of biologic therapy for patients with severe asthma.

Asthma biologic use was not associated with an increase in respiratory infection risk, according to results from the 2026 ...

Among patients with asthma without diabetes, the risk for exacerbation was decreased with GLP-1 receptor agonist exposure, ...

As an add-on maintenance treatment for severe asthma with type 2 inflammation, characterized by blood eosinophil count in adults and adolescents 12 years and older who are inadequately controlled ...

Children with food allergy who used omalizumab plus oral immunotherapy vs. omalizumab alone had similar rates of allergen ...

New Haven, Hartford and Bridgeport are among the 100 worst places for allergies and asthma, according to new data.

Study results suggest immune checkpoint inhibitor therapy may offer immunomodulatory benefits for patients with asthma and ...

KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced new data from its sebetralstat clinical trial program presented ...